Spero Therapeutics, Inc. (SPRO) Q2 2020 Earnings Call Transcript Published 08 Aug 2020 SPRO earnings call for the period ending June 30, 2020. Full Article
Qualigen Therapeutics, Inc. (QLGN) CEO Michael Poirier on Q1 2021 Results - Earnings Call Transcript SeekingAlpha 18 Aug 2020
Fulcrum Therapeutics Inc. (FULC) CEO Robert Gould on Q2 2020 Results - Earnings Call Transcript SeekingAlpha 12 Aug 2020